Tag: Food and Drug Administration

Reflecting on 2016

As 2016 comes to a close, we at 1,000 Days are struck by the important work that has been accomplished – and how much is left to be done. Over the past year we have continued to fight for a healthier future for moms and babies here in the U.S. and around the world. We launched new findings and reports, we worked with new partners and champions, we grew our team – we even added two new babies to our 1,000 Days family!

Here are a few of our highlights from the last year:

  • In January we hand-delivered over 230,000+ petition signatures in support of paid family leave to members of Congress.
  • In April – at an event featuring Bill Gates – we launched a groundbreaking study providing a roadmap for how the world can accelerate progress against malnutrition.
  • Also in April, we sent a letter to President Obama – signed by over 100 athletes – in support of all children receiving a fair start to life with good nutrition.
  • In August we launched our Babies Unite video series in support of ending malnutrition worldwide (which has received over 400,000 views and counting!)
  • In September we released a first-of-its-kind report on nutritional health of America’s mothers, infants and toddlers.
  • In November we urged the presidential candidates to prioritize paid family leave and encouraged the FDA to regulate misleading infant formula marketing.
  • In December we presented findings from qualitative research we conducted to better understand the realities of the first 1,000 days among low-income families in the U.S.

This work would not have been possible without the incredible support of our partners and supporters. You help power our work at 1,000 Days, whether we’re pushing for a national paid family leave policy, fighting for greater investment in programs that save lives of children around the world, or supporting and promoting every woman’s right to breastfeed.

We’ve come a long way this past year, laying the groundwork in our fight for healthy moms and babies. But, there is still more to be done. We look forward to continuing to help build a healthier and more prosperous future for children and their families in the year to come, for there is no better investment we can make than in the health and well-being of our children.

FDA Takes Steps Against Misleading Infant Formula Marketing

More than 1,250 Americans joined 1,000 Days in support of the U.S. Food and Drug Administration’s (FDA) effort to protect families from misleading infant formula marketing.

For the first time ever, the FDA is considering to ask infant formula manufacturers to substantiate claims they make on product labels and marketing materials. They want to encourage makers of formula to provide strong, scientific evidence to back up the health claims they make about their products.

Unsubstantiated claims like “reduces colic” or “aids digestion” are confusing to families who are looking to make decisions about what to feed their babies.

Families who depend on infant formula need to know that the products they are feeding their babies are as effective as the companies claim. That is why the FDA’s recommendations are an important first step in protecting families from bogus health claims made by manufacturers of infant formula.

1,000 Days submitted a letter in support of the FDA’s recommendations and also invited its community of grassroots supporters to add their name to the following letter. And in less than two weeks, 1,259 Americans added their name.

 

November 8, 2016

Susan T. Mayne
Director, Center for Food Safety and Applied Nutrition
c/o Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852

Re: Draft Guidance for Industry on Substantiation for Structure/Function Claims in Infant Formula Labels and Labeling

Dear Dr. Mayne,

It is encouraging to see that for the first time ever, the Food and Drug Administration (FDA) is asking infant formula companies to substantiate the claims made on infant formula labels.

As moms, dads, and caregivers, we have a right to know that the infant formula we buy is safe and effective. We need to have confidence that the claims made on formula labels are accurate and supported by scientific evidence. Companies need to step up and provide credible scientific research to back up the claims they make on their formula, such as “reduces colic” or “aids digestion.”

Given that so many babies in the U.S. rely on infant formula for their nutrition, we believe the FDA also needs to provide stronger oversight of these products and require companies to provide scientific proof that their products deliver the benefits that they claim.

As consumers and parents, we need accurate, credible information about what we’re feeding our babies. Our government needs to do all that it can to protect families from bogus health claims made by manufacturers of formula.

We, the undersigned, applaud the FDA’s proposed Substantiation for Structure/Function Claims Made in Infant Formula Labels and Labeling: Guidance for Industry and encourage the FDA to do more in protecting parents and babies from misleading marketing.

After all, the health and well-being of our country’s babies are at stake.

Sincerely,

1,259 Americans